From Health Affairs Today <[email protected]>
Subject Administration Health Care Executive Order, Drug Importation Plans; Ensuring The Quality Of Generic Medicines
Date September 25, 2020 6:30 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
 

View Message in Browser

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

 

mailto:[email protected]

[link removed]

**The Latest Research, Commentary, and News from Health Affairs**

**Friday, September 25, 2020**

[link removed]

TODAY ON THE BLOG

FOLLOWING THE ACA

Administration Health Care Executive Order

By Katie Keith

On September 24, 2020, President Donald J. Trump issued a new health
care executive order. The order ostensibly focuses on protecting people
with preexisting conditions and eliminating surprise medical bills but
will have little or no immediate effect. Read More >>

PHARMACEUTICALS AND MEDICAL TECHNOLOGY

Administration Finalizes Drug Importation Plans, But Legal And Practical
Questions Remain

By Rachel Sachs

Yesterday, the Trump administration released a final rule aiming to
permit states or other specific actors to establish programs to import
prescription drugs from Canada. This rule is one element of the Trump
administration's broader agenda on drug pricing, but it faces several
large obstacles which are likely to derail its implementation. Read More
>>

COVID-19

A New "PPE" For A Thriving Community: Public Health, Primary Care,
Health Equity

By John M. Westfall, Stephen Petterson, Kyu Rhee, Irene Dankwa-Mullan,
William Kassler, Amol Rajmane, and Glen Mays

Public health, primary care, and health equity each have unique and
synergistic impact on a community's response to COVID-19.
Historically, primary care and public health have only tangentially
worked together. Now, however, there is growing appreciation of the need
for primary care and public health to collaborate if we hope to improve
the health of our nation. Read More >>

[link removed]

IN THE JOURNAL

NARRATIVE MATTERS:
PHARMACEUTICALS & MEDICAL TECHNOLOGY

Challenges In Ensuring The Quality Of Generic Medicines

By Kevin A. Schulman

A refill of a generic attention deficit hyperactivity disorder
prescription leads to new side effects and raises questions about the
quality of generic drugs.Read More >>

Listen to the podcast.

Read the September 2020 Table of Contents
.

Subscribe to Health Affairs for full journal access.

**A CLOSER LOOK**-High-Need Patients

Peter Long's 2017 blog post explains how redesigning the system of
care for the nation's highest-need patients could lead to widely felt
improvements for other patients throughout the health care system. Three
years later, reread the post.

Has the opportunity been missed, or does the chance for progress remain?

[link removed]

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

About Health Affairs

Health Affairs is the leading peer-reviewed journal
at the intersection of health,
health care, and policy. Published monthly by Project HOPE, the journal
is available in print and online. Late-breaking content is also found
through healthaffairs.org , Health Affairs
Today , and Health Affairs
Sunday Update .  

Project HOPE is a global health and
humanitarian relief organization that places power in the hands of local
health care workers to save lives across the globe. Project HOPE has
published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States

Privacy Policy

To unsubscribe from this email, click here
.                 
                                               
                        I
Screenshot of the email generated on import

Message Analysis